TRAVERE THERAPEUTICS, INC. Interest Income (Expense), Net
TRAVERE THERAPEUTICS, INC. (TVTX) reported Interest Income (Expense), Net of $360.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-10-29.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2021-10-29
- TRAVERE THERAPEUTICS, INC. interest income (expense), net for the quarter ending 2021-09-30 was $360.00K, a 67.94% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. interest income (expense), net for the quarter ending 2021-06-30 was $988.00K, a 24.92% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. interest income (expense), net for the quarter ending 2021-03-31 was $409.00K, a 79.30% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. interest income (expense), net for the quarter ending 2020-09-30 was $1.12M, a 54.48% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. interest income (expense), net for fiscal 2018 was $5.50M, a 70.04% increase from fiscal 2017.
- TRAVERE THERAPEUTICS, INC. interest income (expense), net for fiscal 2017 was $3.23M, a 18.64% decline from fiscal 2016.
- TRAVERE THERAPEUTICS, INC. interest income (expense), net for fiscal 2016 was $3.98M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2021-09-30 | $360.00K 10-Q · filed 2021-10-29 | $1.35M derived: sum of 2 quarters · filed 2021-10-29 | $1.76M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $988.00K 10-Q · filed 2021-07-29 | $1.40M 10-Q · filed 2021-07-29 | ||
| 2021-03-31 | $409.00K 10-Q · filed 2021-05-06 | |||
| 2020-09-30 | $1.12M 10-Q · filed 2021-10-29 | $2.44M derived: sum of 2 quarters · filed 2021-10-29 | $4.41M 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $1.32M 10-Q · filed 2021-07-29 | $3.29M 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $1.98M 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | $2.47M 10-Q · filed 2020-11-05 | $5.06M derived: sum of 2 quarters · filed 2020-11-05 | $7.88M 10-Q · filed 2020-11-05 | $10.47M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.59M 10-Q · filed 2020-07-31 | $5.41M 10-Q · filed 2020-07-31 | $8.00M derived: sum of 3 quarters · filed 2020-07-31 | $9.15M derived: sum of 4 quarters · filed 2020-07-31 |
| 2019-03-31 | $2.82M 10-Q · filed 2020-05-11 | $5.41M derived: sum of 2 quarters · filed 2020-05-11 | $6.56M derived: sum of 3 quarters · filed 2020-05-11 | $7.42M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.74M derived: sum of 2 quarters · filed 2019-10-30 | $4.60M derived: sum of 3 quarters · filed 2019-10-30 | $5.50M 10-K · filed 2019-02-26 |
| 2018-09-30 | $1.15M 10-Q · filed 2019-10-30 | $2.00M derived: sum of 2 quarters · filed 2019-10-30 | $2.90M 10-Q · filed 2019-10-30 | $3.58M derived: sum of 4 quarters · filed 2019-10-30 |
| 2018-06-30 | $858.00K 10-Q · filed 2019-08-06 | $1.66M 10-Q · filed 2019-08-06 | $2.43M derived: sum of 3 quarters · filed 2019-08-06 | $3.02M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $797.00K 10-Q · filed 2019-05-07 | $1.57M derived: sum of 2 quarters · filed 2019-05-07 | $2.17M derived: sum of 3 quarters · filed 2019-05-07 | |
| 2017-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.37M derived: sum of 2 quarters · filed 2019-02-26 | $3.23M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $595.00K 10-Q · filed 2018-11-01 | $2.46M 10-Q · filed 2018-11-01 | ||
| 2016-12-31 | $3.98M 10-K · filed 2019-02-26 | |||
| 2015-09-30 | -$700.00K 10-Q · filed 2015-11-06 | $2.20M derived: sum of 2 quarters · filed 2015-11-06 | -$7.40M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $2.90M 10-Q · filed 2015-08-10 | $6.70M 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | $3.80M 10-Q · filed 2015-05-11 | |||
| 2014-09-30 | -$2.60M 10-Q · filed 2015-11-06 | -$400.00K derived: sum of 2 quarters · filed 2015-11-06 | -$4.80M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $2.20M 10-Q · filed 2015-08-10 | $2.20M 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $536.00 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |